Menu

EU Cancer Joint Action EPAAC ends February 2014; new Cancer Joint Action Cancer Control being launched in March 2014:

ECL is Associated Partner on Dissemination, led by Cancer Society of Finland

 READ THE CANCON NEWSLETTERS

 

The cancer Joint Action EPAAC 2011-2014 came to an end in February 2014.  Cancer control remains on the EU agenda with the Joint Action 2014-2017 "Development of the European Guide on Quality Improvement in Comprehensive Cancer Control" ("CanCon") led mainly by Member States.

CANCON continues with the goal of reducing cancer incidence by 15% by 2020:

1) by identifying key elements and quality standards for comprehensive cancer control in Europe and preparing an evidence-based European guide on quality improvement in comprehensive cancer control; and

2) by facilitating cooperation and exchange of best practice between EU countries, to identify and define key elements to ensure optimal, comprehensive cancer care.

 cancon logo horizontal RGB SMALL

The Core Work Packages in the new CanCon Joint Action are as follows:

- Work package 4: Guide Coordination
- Work package 5: Platform for Member States' cooperation
- Work package 6: Integrated cancer care
- Work package 7: Community-level cancer control
- Work package 8: Survivorship & Rehabilitation
- Work package 9: Screening

ECL continues to provide support in the this new Joint Action in the area of dissemination (Work Package 2) with Finland represented by the Cancer Society of Finland, led by its Secretary General Sakari Karjalainen. 

This new Joint Action was launched in March 2014 in Luxembourg.

CanCon Group1

 

More information and summary reports from past consultations on this new Joint Action are available here.

Translate (done by a generic software and translations will be flawed)

English French German Italian Portuguese Russian Spanish
 
 

   

logo_EWAC_transparent_background_w_DATES     cancon logo horizontal RGB SMALL    rarecancers_logo_tagline_rgb_72dpi

 

The text of this webpage is available for modification and reuse under the terms of the Creative Commons Attribution-Sharealike 3.0 Unported License and the GNU Free Documentation License (unversioned, with no invariant sections, front-cover texts, or back-cover texts).

 

 
Go to top